Andre van Rij

Prof. Andre van Rij

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2012 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JHJade E Hollis-Moffatt
Jade E Hollis-Moffatt
APAmanda J Phipps-Green
Amanda J Phipps-Green
BCBrett Chapman
Brett Chapman
GJGregory T Jones
Gregory T Jones
ARAndre van Rij
Andre van Rij
Tony R. MerrimanTony R. Merriman
Tony R. Merriman
Introduction: Two major gout-causing genes have been identified, the urate transport genes SLC2A9 and ABCG2. Variation within the SLC17A1 locus, which encodes sodium-dependent phosphate transporter 1, a renal transporter of uric acid, has also been associated with serum urate concentration. However, evidence for association with gout is equivocal. We investigated the association of the SLC17A1 locus with gout in New Zealand sample sets. Methods: Five variants (rs1165196, rs1183201, rs9358890, rs3799344, rs12664474) were genotyped across a New Zealand sample set totaling 971 cases and 1,742 controls. Cases were ascertained according to American Rheumatism Association criteria. Two population groups were studied: Caucasian and Polynesian. Results: At rs1183201 (SLC17A1), evidence for association with gout was observed in both the Caucasian (odds ratio (OR) = 0.67, P = 3.0 × 10-6) and Polynesian (OR = 0.74, P = 3.0 × 10-3) groups. Meta-analysis confirmed association of rs1183201 with gout at a genome-wide level of significance (OR = 0.70, P = 3.0 × 10-8). Haplotype analysis suggested the presence of a common protective haplotype. Conclusion: We confirm the SLC17A1 locus as the third associated with gout at a genome-wide level of significance.

3 February 2012 in Phlebology: The Journal of Venous Disease
Verified
Journal Article
Closed access
JKJ Krysa
J Krysa
GJG T Jones
G T Jones
ARAndre van Rij
Andre van Rij
There is a strong body of circumstantial evidence which implicates genetics in the aetiology and pathology of varicose veins and venous ulcer disease. The aim of this review is to consider the current knowledge of the genetic associations and the ways in which new genetic technologies may be applied to advancing our understanding of the cause and progression of these venous diseases. A number of publications have used a candidate gene approach to identify genes implicated in venous disease. Although these studies have opened up important new insights, there has been a general failure to replicate results in an independent cohort of patients. With our limited knowledge of the biological pathways involved in the pathogenesis of venous disease we are not in a strong position to formulate truly erudite a priori candidate gene hypothesis-directed studies. A genome wide association study should therefore be considered to help further our understanding of the genetic basis of venous disease. Due to the large sample sizes required for discovery and validation, using the new generations of molecular technologies, it will be necessary to form collaborating groups in order to successfully advance the field of venous disease genetics.

1 June 2017 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
RCRachel Claridge
Rachel Claridge
SASam Arnold
Sam Arnold
NMNeil Morrison
Neil Morrison
ARAndre van Rij
Andre van Rij

1 January 2015 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
KTKate N. Thomas
Kate N. Thomas
JCJames D. Cotter
James D. Cotter
SLSam Lucas
Sam Lucas
BHBrigid G. Hill
Brigid G. Hill
ARAndre van Rij
Andre van Rij

1 October 2013 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
ARAndre van Rij
Andre van Rij
GHGerry Hill
Gerry Hill
JKJo Krysa
Jo Krysa
SDSamantha Dutton
Samantha Dutton
RDRiordon Dickson
Riordon Dickson
CSClive Solomon
Clive Solomon

16 June 2010 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
JHJade E Hollis-Moffatt
Jade E Hollis-Moffatt
MCMichael Chen-Xu
Michael Chen-Xu
RTRuth Topless
Ruth Topless
NDNicola Dalbeth
Nicola Dalbeth
PGPeter J Gow
Peter J Gow
Tony R. MerrimanTony R. Merriman
Tony R. Merriman
Introduction: The single nucleotide polymorphism (SNP) rs6822844 within the KIAA1109-TENR-IL2-IL21 gene cluster has been associated with rheumatoid arthritis (RA). Other variants within this cluster, including rs17388568 that is not in linkage disequilibrium (LD) with rs6822844, and rs907715 that is in moderate LD with rs6822844 and rs17388568, have been associated with a number of autoimmune phenotypes, including type 1 diabetes (T1D). Here we aimed to: one, confirm at a genome-wide level of significance association of rs6822844 with RA and, two, evaluate whether or not there were effects independent of rs6822844 on RA at the KIAA1109-TENR-IL2-IL21 locus. Methods: A total of 842 Australasian RA patients and 1,115 controls of European Caucasian ancestry were genotyped for rs6822844, rs17388568 and rs907715. Meta-analysis of these data with published and publicly-available data was conducted using STATA. Results: No statistically significant evidence for association was observed in the Australasian sample set for rs6822844 (odds ratio (OR) = 0.95 (0.80 to 1.12), P = 0.54), or rs17388568 (OR = 1.03 (0.90 to 1.19), P = 0.65) or rs907715 (OR = 0.98 (0.86 to 1.12), P = 0.69). When combined in a meta-analysis using data from a total of 9,772 cases and 10,909 controls there was a genome-wide level of significance supporting association of rs6822844 with RA (OR = 0.86 (0.82 to 0.91), P = 8.8 × 10-8, P = 2.1 × 10-8 including North American Rheumatoid Arthritis Consortium data). Meta-analysis of rs17388568, using a total of 6,585 cases and 7,528 controls, revealed no significant association with RA (OR = 1.03, (0.98 to 1.09); P = 0.22) and meta-analysis of rs907715 using a total of 2,689 cases and 4,045 controls revealed a trend towards association (OR = 0.93 (0.87 to 1.00), P = 0.07). However, this trend was not independent of the association at rs6822844. Conclusions: The KIAA1109-TENR-IL2-IL21 gene cluster, that encodes an interleukin (IL-21) that plays an important role in Th17 cell biology, is the 20th locus for which there is a genome-wide (P ≤ 5 ×10-8) level of support for association with RA. As for most other autoimmune diseases, with the notable exception of T1D, rs6822844 is the dominant association in the locus. The KIAA1109-TENR-IL2-IL21 locus also confers susceptibility to other autoimmune phenotypes with a heterogeneous pattern of association.